mTOR基因转染对NIH3T3成纤维细胞增殖的影响及其作用机制研究
本文选题:mTOR + 雷帕霉素 ; 参考:《中南大学》2008年博士论文
【摘要】: 目的观察哺乳动物雷帕霉素靶蛋白(mammalian target ofrapamycin,mTOR)基因转染NIH3T3成纤维细胞后细胞增殖情况及对分泌纤连蛋白(fibronectin,FN)的影响,并以雷帕霉素(rapamycin)进行干预,检测Akt-mTOR-p70S6K信号通路中各信号分子及FN的表达,以探讨mTOR基因对成纤维细胞增殖及分泌FN的影响及机制。 方法以氯化钙制备感受态细胞法制备感受态细胞并转化pcDNA3.0-mTOR重组质粒,培养扩增后以碱裂解法抽提质粒,经酶切及DNA测序鉴定,然后通过电穿孔法将质粒转染NIH3T3成纤维细胞,以G418筛选,扩大培养后获得稳定转染细胞株。以雷帕霉素干预转染细胞和非转染细胞,采用MTT法检测细胞增殖力,RT-PCR、Western blot等方法检测细胞Akt、mTOR、p70S6K和FN的表达。应用SPSS11.0统计软件对数据进行统计学分析,计量资料以(?)±s表示,组间比较采用t检验和F检验;计数资料组间比较采用χ~2检验。以P<0.05为差别有显著性统计学意义。 结果 (1)提取的质粒浓度为296ng/μL,OD260/OD280为1.88。双酶切鉴定可见目的基因片段,DNA测序进一步证实为目的基因。 (2)mTOR基因转染成纤维细胞后各基因及蛋白表达的检测结果:mTOR mRNA表达,mTOR/GAPDH光密度值在转染组、对照组分别为0.68±0.03、0.38±0.03(P<0.01);mTOR蛋白表达,mTOR/GAPDH灰度值在转染组、对照组分别为0.79±0.04和0.57±0.01(P<0.01)。FN mRNA表达,FN/GAPDH光密度值在转染组、对照组分别为0.63±0.07、0.39±0.03(P<0.01);FN蛋白表达,FN/GAPDH灰度值在转染组、对照组分别为0.77±0.07和0.55±0.04(P<0.01)。Akt mRNA表达,Akt/GAPDH光密度值在转染组、对照组分别为0.41±0.07、0.39±0.02(P>0.05);Akt蛋白表达,Akt/GAPDH灰度值在转染组、对照组分别为0.65±0.02和0.63±0.03(P>0.05)。p70S6KmRNA表达,p70S6K/GAPDH光密度值在转染组、对照组分别为0.69±0.03、0.34±0.02(P<0.01);p70S6K蛋白表达,p70S6K/GAPDH灰度值在转染组、对照组分别为0.75±0.06、0.53±0.05(P<0.01)。MTT(A值)检测结果:在各时间点A值转染组大于对照组(P<0.01)。 (3)雷帕霉素干预转染前后检测结果:Akt mRNA表达:Akt/GAPDH光密度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.4±0.06、0.39±0.02、0.41±0.05、0.39±0.04。转染组光密度值与其他三组及其他三组之间均无显著性差异(P>0.05)。Akt蛋白表达:Akt/GAPDH灰度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.66±0.02、0.63±0.04、0.67±0.07、0.64±0.05,转染组灰度值与其他三组及其他三组之间均无显著性差异(P>0.05)。p70S6K mRNA表达:p70S6K/GAPDH光密度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.70±0.03、0.34±0.04、0.35±0.02、0.33±0.06。转染组光密度值大于其他三组(P<0.01),其他三组之间无显著性差异(P>0.05)。p70S6K蛋白表达:p70S6K/GAPDH灰度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.76±0.05、0.54±0.04、0.52±0.01、0.53±0.03。转染组灰度值大于其他三组(P<0.01),其他三组之间无显著差异(P>0.05)。FN mRNA表达:FN/GAPDH光密度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.64±0.04、0.40±0.05、0.40±0.03、0.41±0.03。转染组光密度值大于其他三组(P<0.01),其他三组之间无显著差异(P>0.05)。FN蛋白表达:FN/GAPDH灰度值在转染组、对照组、雷帕霉素干预转染组、雷帕霉素干预对照组分别为0.76±0.03、0.53±0.01、0.54±0.02、0.54±0.05。转染组灰度值大于其他三组(P<0.01),其他三组之间无显著性差异(P>0.05)。MTT(A值)检测结果:在各时间点A值转染组大于雷帕霉素干预转染组及对照组、雷帕霉素干预对照组(P<0.01),后三组各时间点A值无显著性差异(P>0.05)。 结论 (1)mTOR基因使成纤维细胞增殖力增强,FN表达增强。 (2)mTOR基因通过Akt-mTOR-p70S6K信号通路发挥作用,不一定依赖Akt的激活。 (3)雷帕霉素可通过阻断mTOR-p70S6K信号通路而抑制成纤维细胞增殖及FN的合成。
[Abstract]:Objective To observe the proliferation of mammalian target ofrapamycin (mTOR) gene transfected by rapamycin ofrapamycin (mTOR) gene and the effect on the secretion of fibronectin (fibronectin, FN) in NIH3T3 fibroblasts, and to detect the expression of each signal molecule and FN in the Akt-mTOR-p70S6K signal pathway by using rapamycin (rapamycin) to detect the expression of each signal molecule and FN in the Akt-mTOR-p70S6K signal pathway. To explore the effect and mechanism of mTOR gene on proliferation and secretion of FN in fibroblasts.
Methods using calcium chloride to prepare susceptible cells and transform pcDNA3.0-mTOR recombinant plasmid, the plasmid was extracted by alkali lysis and identified by enzyme digestion and DNA sequencing. Then transfected by electroporation, the plasmid was transfected into NIH3T3 fibroblasts, and the stable transfected cell line was obtained by G418 screening. The cells and non transfected cells were transfected by MTT, and the expression of cell Akt, mTOR, p70S6K and FN were detected by RT-PCR and Western blot. The data were statistically analyzed with SPSS11.0 statistical software. The measurement data were expressed with (?) + s, t test and F test were used in the group, and the count data were compared by chi square The difference was statistically significant between P < 0.05.
Result
(1) the plasmid concentration was 296ng/ L, OD260/OD280 was 1.88., and the target gene fragment was identified by double enzyme digestion. DNA sequencing further confirmed the target gene.
(2) the detection results of gene and protein expression of mTOR gene transfected into fibroblasts: mTOR mRNA expression, mTOR/GAPDH light density value in transfection group and control group 0.68 + 0.03,0.38 + 0.03 (P < 0.01), mTOR protein expression, mTOR/GAPDH gray value in transfected group, and control group were 0.79 + 0.04 and 0.57 + 0.01 (P < 0.01).FN mRNA expression, respectively. FN/GAP The value of DH light density was 0.63 + 0.07,0.39 + 0.03 (P < 0.01) in the control group, and the expression of FN protein was expressed in the transfected group, and the control group was 0.77 + 0.07 and 0.55 + 0.04 (P < 0.01).Akt mRNA, respectively. The Akt/GAPDH light density value was in the transfected group, and the control group was 0.41 + 0.07,0.39 + 0.02 (P > 0.05), and the Akt protein was expressed. The value of gray value in the transfection group was 0.65 + 0.02 and 0.63 + 0.03 (P > 0.05).P70S6KmRNA respectively. The p70S6K/GAPDH light density value was 0.69 + 0.03,0.34 + 0.02 (P < 0.01) in the control group, and the p70S6K protein expression was expressed in the transfected group, and the p70S6K/GAPDH gray value was in the transfected group, and the group was 0.75 + 0.06,0.53 + 0.05 (P < 0.01).MTT (A), respectively. Results: at each time point, the A value transfection group was larger than that of the control group (P < 0.01).
(3) the results of rapamycin intervention before and after transfection: Akt mRNA expression: Akt/GAPDH light density value in transfection group, control group, rapamycin intervention group, the light density value of 0.4 + 0.06,0.39 + 0.02,0.41 + 0.05,0.39 + 0.04. transfection group with rapamycin control group, and no significant difference between the three groups and the other three groups (P > 0.05) The expression of.Akt protein: Akt/GAPDH gray value in transfection group, control group, rapamycin intervention group, rapamycin control group was 0.66 + 0.02,0.63 + 0.04,0.67 + 0.07,0.64 + 0.05 respectively, and there was no significant difference between the gray value of the transfected group and the other three groups and other three groups (P > 0.05).P70S6K mRNA expression: p70S6K/GAPDH light density value in the group The transfection group, control group, rapamycin intervention group, the light density value of 0.70 + 0.03,0.34 + 0.04,0.35 + 0.02,0.33 + 0.06. transfection group with rapamycin control group was greater than the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).P70S6K protein expression: p70S6K/GAPDH gray value in transfection group, control group, rapamycin The gray value of 0.76 + 0.05,0.54 + 0.04,0.52 + 0.01,0.53 + 0.03. transfection group in the control group was greater than that of the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).FN mRNA expression: the FN/GAPDH light density value was in the transfection group, the control group, the rapamycin intervention group, and the rapamycin intervention control The light density value of the group of 0.64 + 0.04,0.40 + 0.05,0.40 + 0.03,0.41 + 0.03. transfection group was greater than that of the other three groups (P < 0.01). There was no significant difference between the other three groups (P > 0.05).FN protein expression: the gray value of FN/GAPDH was in the transfection group, the control group, the rapamycin intervention group, the control group was 0.76 + 0.03,0.53 + 0.01,0.54 + 0., respectively. The gray value of 02,0.54 + 0.05. transfection group was greater than that of the other three groups (P < 0.01), there was no significant difference between the other three groups (P > 0.05).MTT (A value) detection results: at every time point, A value transfection group was greater than rapamycin intervention group and control group, rapamycin intervention control group (P < 0.01), and there was no significant difference between the three groups at each time point A value (P > 0.05).
conclusion
(1) mTOR gene increased the proliferation of fibroblasts and enhanced the expression of FN.
(2) mTOR gene plays a role through Akt-mTOR-p70S6K signaling pathway, and does not necessarily depend on Akt activation.
(3) rapamycin can inhibit fibroblast proliferation and FN synthesis by blocking mTOR-p70S6K signaling pathway.
【学位授予单位】:中南大学
【学位级别】:博士
【学位授予年份】:2008
【分类号】:R346
【相似文献】
相关期刊论文 前10条
1 刘凯;孙灵敏;刘建文;;雷帕霉素洗脱支架置入抑制猪TNF-α表达[J];基础医学与临床;2011年09期
2 杨臻峥;;雷帕霉素或可延缓早老综合征患者疾病进程[J];药学进展;2011年07期
3 李芹芹;史道华;杨牛牛;;基于雷帕霉素与FRB结合的蛋白质间相互作用的相关技术[J];生物技术通报;2011年09期
4 刘锡君;李新;郑水娣;钟丹;章康健;王世兵;周秀梅;;雷帕霉素联合ZD55-TRAIL病毒对肿瘤抑制及其机制探讨[J];中国细胞生物学学报;2011年06期
5 刘法昱;李鹏;赵震锦;丁雪;孙长伏;;人头颈鳞癌CCR7和mTOR表达关系研究[J];中国实用口腔科杂志;2011年07期
6 王德光;李学旺;李航;陈丽萌;段琳;李艳;刘华;;雷帕霉素对KKAy小鼠体重及胰岛素抵抗的影响[J];中国糖尿病杂志;2007年02期
7 李敏娜;;新型免疫抑制剂雷帕霉素的研究进展[J];河北化工;2011年08期
8 鄂亚军;贺能树;范海伦;李志强;;雷帕霉素局部缓释对血管成形术后血管壁及其TF表达的影响[J];临床放射学杂志;2011年08期
9 朱小青;;mTOR激活剂磷脂酸对SH-SY5Y细胞氧化应激和Tau蛋白磷酸化的调节[J];中国病理生理杂志;2011年06期
10 齐晓云;徐萍;杨洋;李春华;王万粮;东洋;;血浆组织因子及其途径抑制物对急性心肌梗死患者雷帕霉素支架置入后血栓形成的影响[J];中国医科大学学报;2011年07期
相关会议论文 前10条
1 张彤;梅长林;付莉莉;熊锡山;王丽;戴兵;;骁悉和雷帕霉素对常染色体显性多囊肾病治疗作用的实验研究[A];2007年浙沪两地肾脏病学术年会资料汇编[C];2007年
2 沈晓芸;刘芳;唐乙;王全兴;;雷帕霉素促进Foxp3~+CD4~+CD25~+Treg细胞产生的分子机制[A];第六届全国免疫学学术大会论文集[C];2008年
3 华雯;刘慧;夏丽霞;田宝平;陈志华;李雯;沈华浩;;雷帕霉素对哮喘小鼠骨髓嗜酸粒细胞祖细胞分化的影响[A];2011年第三十三届浙江省呼吸系病学术年会暨呼吸疾病诊治新进展学习班论文汇编[C];2011年
4 赵妍敏;周倩;黄河;;雷帕霉素对Jurkat细胞作用及机制研究[A];2007年浙江省血液病学术年会论文汇编[C];2007年
5 李学旺;;雷帕霉素在慢性肾脏疾病治疗中的作用[A];中华医学会肾脏病学分会2006年学术年会专题讲座[C];2006年
6 蔡勇;陈琰;郑少玲;陈必成;夏鹏;杨亦荣;;雷帕霉素对于蛋白负荷肾病大鼠模型肾脏的影响[A];2007年浙江省器官移植学术会议论文汇编[C];2007年
7 张胜利;祝仕清;牛长群;;国产雷帕霉素在恒河猴的药代动力学研究[A];2002年灵长类实验动物学术交流会论文摘要集[C];2002年
8 程元荣;郑卫;;新分子靶位mTOR与雷帕霉素类药物[A];创新药物及新品种研究、开发学术研讨会论文集[C];2006年
9 尤庆生;陈宏林;孟小勇;;血管外雷帕霉素缓释涂层抑制桥静脉再狭窄的实验观察[A];中华医学会第七次全国胸心血管外科学术会议暨2007中华医学会胸心血管外科青年医师论坛论文集心血管外科分册[C];2007年
10 董莹;黄一飞;皮裕璃;;雷帕霉素对角膜移植术后VEGF的影响[A];中华医学会第十二届全国眼科学术大会论文汇编[C];2007年
相关重要报纸文章 前10条
1 本报记者 白毅;mTOR信号通路为肿瘤治疗提供新靶点[N];中国医药报;2010年
2 本报特约撰稿人 徐铮奎;雷帕霉素:新用途催生大市场[N];医药经济报;2009年
3 驻京记者 李瑶;mTOR提供癌症治疗新思路[N];医药经济报;2010年
4 欧飒;或许真有“长寿药”,但真能带来快乐?[N];新华每日电讯;2009年
5 马艳红;雷帕霉素药物释放支架安全、有效[N];中国医药报;2002年
6 实习生 李娜 本报记者 袁志勇;新发现可以阻断肿瘤通路吗[N];科技日报;2010年
7 方方;雷帕霉素药物支架可降低冠心病再梗率[N];医药经济报;2006年
8 本报记者 冯卫东;雷帕霉素成为首种可延长哺乳动物寿命的药物[N];科技日报;2009年
9 周婷玉 g品,
本文编号:2070270
本文链接:https://www.wllwen.com/yixuelunwen/shiyanyixue/2070270.html